Phases in a drug's use

Duffin, Jacalyn
September 1992
CMAJ: Canadian Medical Association Journal;9/1/1992, Vol. 147 Issue 5, p588
Academic Journal
No abstract available.


Related Articles

  • Immunosuppressive Drugs for Kidney Transplantation. Halloran, Philip F. // New England Journal of Medicine;12/23/2004, Vol. 351 Issue 26, p2715 

    Focuses on agents that are either approved or in phase 2 or phase 3 trials in kidney transplantation. Model of the alloimmune response to illustrate how these medications act; Description of immunosuppressive drugs and their use in transplantation; How these drugs are used; Analysis of their...

  • Renal diseases.  // Formulary;Feb2010, Vol. 45 Issue 2, p72 

    A chart is presented which shows the U.S. Food and Drug Administration (FDA) approval phase for drugs used in the treatment of renal diseases.

  • Another agent for IBS in late-stage development.  // Formulary;Aug99, Vol. 34 Issue 8, p642 

    Reports on the result of the phase III trial for the drug HTF 919 used for the treatment of irritable bowel syndrome.

  • Biomaterials: Biology researcher on verge of major breakthrough in drug creation process.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article presents information on the new method for the first phase of drug creation process used by the pharmaceutical companies.

  • trial, phase 3.  // Taber's Cyclopedic Medical Dictionary;2005, p2233 

    A definition of the term "phase 3 trial" is presented. It refers to a clinical trial for the determination of the clinical use of a new drug.

  • Controlled Trial Methodology and Progress in Treatment of the Acquired Immunodeficiency Syndrome (AIDS). Broder, Samuel // Annals of Internal Medicine;3/15/89, Vol. 110 Issue 6, p417 

    Editorial. Addresses progress in the use of controlled trials in development of drugs for AIDS. Issues that will affect the pace and overall success of drug development in the future; Definition of Phase I studies in AIDS research; Basis of progress in development of drugs for AIDS.

  • Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Marona-Lewicka, Danuta; Thisted, Ronald A.; Nichols, David E. // Psychopharmacology;Jul2005, Vol. 180 Issue 3, p427 

    Presents a study on distinct temporal phases in the behavioral pharmacology of LSD drug in rats. Drug discrimination training and testing procedures used in the study; Analysis of data from the drug discrimination study; Results of the study.

  • New drug is first to be OK'd for biopolar depression. LoBuono, Charlotte // Drug Topics;1/26/2004, Vol. 148 Issue 2, p22 

    Reports on the use olanzapine for the treatment of depressive episodes associated with bipolar disorder in the U.S. Approval of the drug by the Food and Drug Administration; Metabolism of the drug; Elevation in the core body temperature; Assessment of the phase of the illness.

  • Neurocrine reports positive results for Indiplon phase III trial in elderly patients with chronic insomnia.  // PharmaWatch: CNS;April 2004, Vol. 3 Issue 4, p10 

    Announces the positive results from the phase III clinical trial for indiplon by Neurocrine Biosciences Inc. Usefulness of the drugs in treating chronic insomnia in elderly patients; Detection of the improvement in the duration of the time to sleep with the drug; Tolerance of patients of the drug.

  • TUNE IN, TURN ON, PASS OUT, TYPE UP. Wolcott, James // Vanity Fair;Nov2002, Issue 507, p190 

    Identifies five stages of drug abuse meltdown that turned many rock musicians into vegetables with entourages. Initiation into the culture of drug use within the industry; Phase of intoxication when users need to fuel a glory ride and creativity; Introduction to the enthrallment phase as the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics